Article -> Article Details

Market Overview

The global infertility treatment devices market was valued at USD 474.9 Million in 2024. It is projected to reach USD 761.7 Million by 2033, growing at a CAGR of 5.12% during 2025-2033. Market growth is driven by rising infertility rates, technological advancements in assisted reproductive technologies, increasing delayed parenthood, and various government initiatives. Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Infertility Treatment Devices Market Key Takeaways

• The market size was USD 474.9 Million in 2024.
• The market is expected to grow at a CAGR of 5.12% during 2025-2033.
• The forecast period extends from 2025 to 2033.
• Increasing fertility clinics worldwide are boosting market growth.
• Sedentary lifestyles resulting in chronic diseases like diabetes, obesity, and hypertension increase infertility risks.
• Rising use of ART procedures like IVF and availability of treatment devices positively impact the market.
• Government initiatives and public-private investments are enhancing treatment accessibility.
• North America dominates due to innovations in medical devices and supportive policies.

Sample Request Link: https://www.imarcgroup.com/Infertility-Treatment-Devices-Market/requestsample

Market Growth Factors

The infertility treatment devices market is driven by the rise in fertility clinics around the world, in which assisted reproductive technologies (ART) are usually provided. Living a sedentary lifestyle and acquiring chronic diseases such as diabetes, obesity, and hypertension, cause infertility among both men and women, creating an increased demand for infertility treatment devices.

Technological advances in ART and IVF, like ICSI and cryopreservation, increase ART success rates. Automation of ART procedures is reducing the number of operational steps required to as low as one quarter with the introduction of motorized inverted microscopes, such as the Nikon ECLIPSE Ti2-I discussed in the International Journal of In Vitro Fertilization, which are increasing ART use and sales.

Government bodies also set policies and subsidize so people access treatment in some countries. In February 2024, the Maharashtra state government in India announced, for example, free IVF treatment inside government hospitals to residents who need procedures costing more than INR 2 lakhs (US$2,500). Public institutions also help in increasing the market penetration for infertility devices considerably.

Market Segmentation

By Type:

• Sperm Separation Devices: Demand is growing due to rising male infertility linked to lifestyle and environmental toxins; these devices isolate healthy sperm for procedures like ICSI and IVF.
• Ovum Aspiration Pumps: Essential in IVF, the rising IVF cycles drive demand for ovum aspiration pumps.
• Sperm Analyzer Systems: High demand for analyzing sperm count, motility, morphology, and viability amid rising male infertility.
• Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscopes, Others: Included but no specific data beyond listing.

By Patient Type:

• Female Infertility Treatment: Delayed motherhood, rise in PCOS, endometriosis, and premature ovarian failure increase demand for female infertility treatments including ART.
• Male Infertility Treatment: Growing awareness of male infertility has increased use of sperm analysis, genetic testing, and micromanipulation tools.

By End User:

• Fertility Clinics: Primary providers of ART such as IVF and ICSI; demand for specialized devices like sperm separation devices, incubators, cryosystems, and microscopes is high.
• Hospitals and Other Healthcare Facilities: Provide initial diagnosis and treatments; demand for sperm analyzers, microscopes, and imaging systems is notable.
• Clinical Research Institutes: Involved in developing fertility technologies, requiring advanced devices like micromanipulators and imaging systems for research.

By Region:

• North America (United States, Canada), Europe (Germany, France, UK, Italy, Spain, Russia), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia), Latin America (Brazil, Mexico), Middle East and Africa.

Regional Insights

North America dominates the infertility treatment devices market, driven by increasing infertility rates, innovative reproductive technologies, and widespread awareness of ART procedures like IVF. Europe’s growth is supported by government reimbursement policies for fertility treatments. Asia Pacific benefits from its large population base and rising infertility linked to lifestyle changes, delayed marriages, and urbanization.

Recent Developments & News

• July 2024: Nikon Corporation launched the ECLIPSE Ti2-I Motorized Inverted Microscope to enhance micro-insemination efficiency, reducing operational steps by approximately 75%.
• July 2024: Mira introduced an online Hormone Health Clinic for Fertility, providing at-home reproductive health solutions.
• May 2024: May Health secured $25 million funding for clinical trials of a less invasive outpatient infertility treatment for PCOS.

Key Players

• Ab Scientific Ltd
• Cook Group Incorporated
• Coopersurgical Inc. (The Cooper Companies Inc.)
• Eppendorf
• Esco Micro Pte. Ltd.
• Genea Limited
• Hamilton Throne Ltd.
• Kitazato Corporation
• Rocket Medical plc
• Thermo Fisher Scientific
• Thomas Medical (Medgyn Products Inc.)
• Vitrolife

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=5710&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302